Peptide Research
Thymalin: A Thymus Extract From the Soviet Peptide Programme
Thymalin is an extract rather than a defined compound, from a Soviet-era research programme whose literature is real, extensive, and almost entirely un-replicated in the West.
Peptide Library Editorial · September 26, 2026 · 2 min read
Thymalin is not a single molecule. It is a preparation of peptides extracted from calf thymus tissue — a mixture, in the same sense that cerebrolysin is a mixture.
It comes from the Soviet-era peptide research programme associated with Vladimir Khavinson, which produced a family of tissue-derived preparations still sold today.
Not an approved drug. Thymalin, in the US, EU, or UK has no approved human indication in the US, EU, or UK and no established human dose. It is sold for laboratory research only, and nothing here is dosing guidance.
Extract, not compound
This distinction governs everything else. For a defined synthetic peptide, purity has a clear meaning and a certificate of analysis can establish identity and content.
For a tissue extract none of that applies cleanly:
No single target peak. The product is a distribution of fragments, so a single-peak HPLC purity figure is meaningless.
Batch consistency depends on process. Not on synthesising one molecule correctly.
Animal-sourced. Which introduces considerations synthetic peptides do not have.
Composition may vary. Between manufacturers and between batches.
A "99% purity" COA for thymalin is a red flag, not reassurance. A mixture cannot present as a single peak. If a certificate shows one, it was not produced for this product.
How it differs from thymosin alpha-1
The two are frequently conflated because both relate to the thymus and immune function. They are not the same thing.
Thymalin | Thymosin alpha-1 | |
|---|---|---|
What it is | Tissue extract, a mixture | Defined 28-amino-acid peptide |
Can be characterised | Not as a single molecule | Yes — sequence and mass |
Approval | Not in the US, EU, or UK | Approved in many countries |
Evidence base | Largely one research tradition | International clinical literature |
Thymosin alpha-1 is the better-evidenced option by a considerable margin, and the one with approvals behind it.
Reading the evidence
The thymalin literature is real and extensive, and concentrated in one national research tradition — much of it published in Russian-language journals with limited independent Western replication.
That is the same evidentiary position as Semax and Selank and epitalon. It is a specific limitation on confidence, not a verdict that the findings are wrong.
Storage
Storage is the same as any reconstituted vial: 2–8 °C, protected from light, never frozen, and bounded by the shorter of peptide stability and the 28-day limit on bacteriostatic water. The bacteriostatic water guide covers the detail.
Frequently asked questions
Is thymalin the same as thymosin alpha-1?
No. Thymalin is a tissue extract; thymosin alpha-1 is a single defined peptide with international approvals.
Can its purity be verified?
Not the way a synthetic peptide's can. For an extract, the relevant assurance is manufacturing process control.
Why is the research hard to assess?
Language, journal accessibility, and concentration in one research tradition with limited independent replication.
Research and educational use only. Peptide Library is an independent research and comparison platform and does not sell peptides. Nothing here is medical advice, dosing guidance, or a recommendation to administer any substance to a person or an animal. Consult a licensed clinician for anything concerning human health.
Sources
Author
Peptide Library Editorial
Editorial content from Peptide Library. Research and educational use only. Not medical advice.
Related articles
Related peptides
Related tools
Research smarter with Peptide Library.
Compare peptides, review vendor data, and use research calculators in one place.
Explore the LibraryResearch and educational use only. Not medical advice. Peptide Library does not sell peptides.